| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 9.025 | 6.265 | 3.663 | 6.367 | 4.838 | 1.747 | - | - | - | - |
| Total Income - EUR | 9.009 | 6.265 | 3.663 | 6.367 | 4.838 | 1.747 | - | - | - | - |
| Total Expenses - EUR | 9.718 | 7.289 | 4.707 | 7.028 | 7.034 | 6.589 | - | - | - | - |
| Gross Profit/Loss - EUR | -709 | -1.023 | -1.044 | -661 | -2.196 | -4.842 | - | - | - | - |
| Net Profit/Loss - EUR | -979 | -1.211 | -1.155 | -852 | -2.341 | -4.890 | - | - | - | - |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | - | - | - | - |
Check the financial reports for the company - Avicena Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.460 | 1.445 | 1.421 | 1.395 | 1.368 | 1.342 | - | - | - | - |
| Current Assets | 3.942 | 4.134 | 2.832 | 3.031 | 3.075 | 2.805 | - | - | - | - |
| Inventories | 1.450 | 115 | 237 | 276 | 296 | 91 | - | - | - | - |
| Receivables | 1.711 | 1.771 | 1.971 | 2.144 | 2.163 | 2.142 | - | - | - | - |
| Cash | 781 | 2.249 | 623 | 610 | 615 | 572 | - | - | - | - |
| Shareholders Funds | -21.628 | -22.618 | -23.390 | -23.813 | -25.693 | -30.096 | - | - | - | - |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | - | - | - | - |
| Debts | 27.030 | 28.197 | 27.643 | 28.238 | 30.135 | 34.243 | - | - | - | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8513 - 8513" | |||||||||
| CAEN Financial Year |
8513
|
|||||||||
Comments - Avicena Srl